EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Mismatch Repair Status and Lymph Node Ratio in Survival Prediction of Stage II / III Rectal Cancer Patients: A Comprehensive Analysis of a Multi‐Center Retrospective Study

Kailong Zhao iD, Wenwen Pang, Xinyu Liu, Kemin Ni, Weifeng Gao, Zhiquan Tan, Jun Xue, Weizheng Liang, Xueliang Wu, Xipeng Zhang, Xiaomin Su, Chunze Zhang iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.70756 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, 2025. Verfasst von Kailong Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: DNA Mismatch Repair, Rectal Neoplasms, Lymph Node Ratio, Lymph Nodes. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Management Research Project of Tianjin Hospital Association, Tianjin Key Medical Discipline Construction Project, Tianjin Health Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The microsatellite status (dMMR vs. pMMR) in colorectal cancer can serve as a guiding factor for patient prognosis and treatment, where dMMR status indicates a better prognosis and often obviates the need for adjuvant chemotherapy (ACT). Conversely, a higher lymph node ratio (LNR) is associated with a poorer prognosis. This study aims to elucidate the prognostic significance of LNR and MMR status in relation to ACT in stages II and III colorectal cancer.

Methods

A total of 1946 patients who underwent radical resection for colorectal cancer and were pathologically staged as II and III from three medical centers between 2012 and 2019 were selected. Among them, 1104 patients were included after MMR status was tested and postoperative chemotherapy was administered, along with other clinical information. MMR (mismatch repair) status was determined via pathological immunohistochemistry (IHC), and LNR was calculated. Patients were divided into three groups based on the LNR value and subjected to Kaplan–Meier and Cox regression analysis to assess the impact of MMR, LNR, and ACT on overall survival (OS) and disease‐free survival (DFS).

Results

A total of 6.47% of stage II and III colorectal cancers were detected as dMMR. Significant differences in OS and DFS between dMMR and pMMR patients were observed when the LNR ranged from 0.03 to 0.31, with pMMR patients showing a better prognosis. Stratified analysis with ACT revealed that postoperative chemotherapy did not affect the prognosis within the dMMR patient group. However, compared to the pMMR group, dMMR patients experienced significantly adverse effects on prognosis after receiving postoperative chemotherapy ( p < 0.05). This result was more pronounced in the stratified analysis based on LNR (0.03–0.31) ( p < 0.01).

Conclusions

Integrating LNR based on the microsatellite status of colorectal tumors provides comprehensive prognostic predictions, enhancing postoperative prognostic considerations for tumor patients. Additionally, our study suggests that patients with stage II and III colorectal cancer with dMMR status do not require any adjuvant chemotherapy postoperatively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Mismatch RepairRectal NeoplasmsLymph Node RatioLymph NodesHumansFemaleMaleRetrospective StudiesMiddle AgedAgedNeoplasm StagingPrognosisAdultMicrosatellite InstabilityChemotherapy, AdjuvantLymphatic MetastasisAged, 80 and over

Stichwörter der Autor:innen

adjuvant chemotherapy (ACT)lymph node ratio (LNR)microsatellite instability (dMMR)survival

Autor:innen und Institutionen

  • School of Medicine, Nankai University, Tianjin, China.
  • Department of Colorectal Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
  • Department of Clinical Laboratory, Tianjin Union Medical Center, Tianjin, China.
  • Tianjin Medical University, Tianjin, China.
  • The Institute of Translational Medicine, Tianjin Union Medical Center, Tianjin, China.
  • Tianjin Institute of Coloproctology, Tianjin, China.

ORCID-Profile: Kailong Zhao, Chunze Zhang

Förderung

  • Hospital Management Research Project of Tianjin Hospital Association
  • Tianjin Key Medical Discipline Construction Project
  • Tianjin Health Technology Project
  • This research was supported by the Key Research Project of Tianjin Science and Technology Support Program
  • Tianjin Natural Science Foundation
  • Hebei Basic Research Cooperation Project
  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Zhao, K., Pang, W., Liu, X., Ni, K., Gao, W., Tan, Z., Xue, J., Liang, W., Wu, X., Zhang, X., Su, X., & Zhang, C. (2025). Mismatch Repair Status and Lymph Node Ratio in Survival Prediction of Stage II / III Rectal Cancer Patients: A Comprehensive Analysis of a Multi‐Center Retrospective Study. Cancer Medicine. https://doi.org/10.1002/cam4.70756

Vancouver

Zhao K, Pang W, Liu X, Ni K, Gao W, Tan Z, et al. Mismatch Repair Status and Lymph Node Ratio in Survival Prediction of Stage II / III Rectal Cancer Patients: A Comprehensive Analysis of a Multi‐Center Retrospective Study. Cancer Medicine. 2025. doi:10.1002/cam4.70756

BibTeX
@article{Zhao2025,
  author = {Zhao, Kailong and Pang, Wenwen and Liu, Xinyu and Ni, Kemin and Gao, Weifeng and Tan, Zhiquan and Xue, Jun and Liang, Weizheng and Wu, Xueliang and Zhang, Xipeng and Su, Xiaomin and Zhang, Chunze},
  title = {Mismatch Repair Status and Lymph Node Ratio in Survival Prediction of Stage II / III Rectal Cancer Patients: A Comprehensive Analysis of a Multi‐Center Retrospective Study},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70756}
}
Kostenlos starten →